Recursion AI-guided oncology research collaboration
Research partnerships Announcement
Disclosed: Verified: Partners: Recursion
Bayer and Recursion focused their research collaboration on precision oncology, using Recursion's AI-guided drug discovery platform. They may initiate up to seven oncology programs, and Recursion is eligible for up to $1.5 billion plus royalties on net sales.
up to $1.5 billion plus royalties on net sales; up to seven oncology programs company-reported
Source
Company Archive pending